Updated Jul 16, 2026
Ben-Elazar Pini has filed 1 SEC Form 4 filing across 1 company in the last 90 days.

Ben-Elazar Pini is listed as a Director of Regentis Biomaterials Ltd. in SEC filings, with the most recent filing dated July 13, 2026. Regentis Biomaterials Ltd. operates in the biomaterials sector. The available SEC context confirms his role on the board, but there is limited public information provided in the context about his broader career background or education.
| Role | Director |
|---|---|
| Notability | 20/100 |
Ben-Elazar Pini is listed as a Director of Regentis Biomaterials Ltd. in SEC filings, with the most recent filing dated July 13, 2026. Regentis Biomaterials Ltd. operates in the biomaterials sector. The available SEC context confirms his role on the board, but there is limited public information provided in the context about his broader career background or education.…
1 primary Form 4 filings in the last 90 days, covering 1 company.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Ben-Elazar Pini profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.